Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2025-12-24 @ 8:02 PM
NCT ID:
NCT06582004
Eligibility Criteria:
Inclusion Criteria:
* Female individuals aged 20 years (inclusive) or older who have abnormal Pap smear results and have been diagnosed with CIN1 via colposcopy biopsy, and are also positive for high-risk HPV. This includes:
* Patients with Pap smear results of CIN2, ASCUS, or CIN1 who have undergone colposcopic biopsy of suspicious lesions or random biopsies, with pathology confirming CIN1.
* Patients with Pap smear results of CIN1 who have undergone colposcopic biopsy of suspicious lesions or random biopsies, and where the biopsy sample is insufficient for diagnosis or the biopsy pathology is normal.
Exclusion Criteria:
* Female patients who are currently pregnant, planning to become pregnant, or are underage.
* Patients with an allergy to the ingredients in CH2 Natural Purifying Protection Serum.
* Patients diagnosed with CIN2, CIN3, or higher through colposcopic biopsy.
* Patients with urinary tract or pelvic infections.
* Patients with significantly impaired cognitive function.
* Patients who are unable to self-administer vaginal gel.
* Patients with immunocompromised conditions, end-stage liver or kidney disease, those using steroids, or those who have previously undergone total hysterectomy.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Study:
NCT06582004
Study Brief:
Protocol Section:
NCT06582004